Abstract
Clinical trials with IFN-α, produced from buffy coats of leukocytes, have been going on at Radiumhemmet, Karolinska Hospital since 1969. In some of the benign and malignant tumor diseases studied, IFN has been shown to induce regressions. In the case of the benign tumor juvenile laryngeal papillomatosis, IFN has been shown to be superior to other treatment modalities. So far IFN has not been shown to be superior to conventional treatment in any of the malignant tumors studied.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gresser I: Antitumor effects of interferon, in Becker F (ed):Cancer, a Comprehensive Treatise, p. 521. New York, Plenum Press (1977).
Cantell K, Hirvonen S: Large scale production of human leukocyte interferon containing 108 units per ml.J gen Virol 39, 541 (1978).
Haglund S, Lundquist P-G, Cantell K, Strander H: Interferon therapy in juvenile laryngeal papillomatosis.Arch Otolaryngol 107, 327 (1981).
Goepfert H, Gutterman J, Dichtel W, Sessions R B, Cangir A, Sulek M: Leukocyte interferon in patients with juvenile laryngeal papillomatosis.Ann Otol Rhinol Laryngol 91, 431 1982).
McCabe B F, Clark K F: Interferon in laryngeal papillomatosis.Ann Otol Rhinol Laryngol 92, 2 (1983).
Strander H, Aparisi T, Broström L-Å, Einhorn S, Ingimarsson S, Nilsonne U, Söderberg G: Adjuvant interferon therapy of human osteosarcoma, inCurrent Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors. Ottawa, Canada (1983) (In press).
Mellstedt H, Ahre A, Björkholm M, Holm G, Johansson B, Strander H: Interferon therapy in myelomatosis.Lancet 1, 245 (1979).
Einhorn N, Cantell K, Einhorn S, Strander H: Human leukocyte interferon therapy in advanced ovarian carcinoma.Cancer Clin Trials 5, 167 (1982).
Paucker K, Cantell K, Henle W: Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells.Virology 17, 324 (1962).
Einhorn S, Strander H: Interferon therapy for neoplastic diseases in man.In vitro andin vivo studies, inHuman Interferon. Production and Clinical Use, p. 159, Lake Placid, U.S.A., W. Alton Jones Cell Science Center (1977).
Ernberg I, Einhorn S, Strander H, Klein G: Proliferation inhibitory effect of interferon on primary explants of Burkitt lymphoma: inverse relationship to patient survival.Biomedicine 35, 190 (1981).
Einhorn S, Blomgren H, Jarstrand C, Strander H, Wasserman J: Influence of interferon-α therapy on functions of the human immune system, in, De Maeyer E, Galasso G, Schellekens H (eds)The Biology of the Interferon System. Amsterdam, Elsevier/North-Holland (1983) (In press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Einhorn, S., Strander, H. Studies with interferon-α in human tumors. Med. Oncol. & Tumor Pharmacother. 1, 97–99 (1984). https://doi.org/10.1007/BF02934980
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02934980